Lisa Horvath, MBBS, PhD
About Lisa Horvath, MBBS, PhD
Dr. Lisa Horvath is the Director of the Department of Medical Oncology at Chris O’Brien Lifehouse. She completed medical school at the University of Sydney and trained in medical oncology at Royal Prince Alfred Hospital, where she was appointed to the senior staff in 2003. She completed her PhD in translational research at the Garvan Institute of Medical Research in 2004. Lisa’s research interest is predominantly in the field of prostate cancer. She is involved with a large number of clinical trials in prostate and colorectal cancers. Dr. Horvath is currently working on research that looks at patients’ blood markers which can predict resistance to chemotherapy in metastatic prostate cancer, as well as the development of new drugs to treat chemotherapy resistance.
Lisa holds academic appointments at both the University of Sydney and the University of New South Wales and is the head of Prostate Cancer Therapeutics at The Kinghorn Cancer Centre/Garvan Institute of Medical Research. She is the conjoint chair of Medical Oncology (Genitourinal Cancers) at Lifehouse. Lisa has published more than 50 original research papers published in peer-reviewed journals in the last 14 years. She has presented extensively at national and international meetings both peer-reviewed and invited presentations.